RecruitingNot Applicable

Atrial Functional Mitral Regurgitation and Tricuspid Regurgitation

United Kingdom141 participantsStarted 2023-08-23

Plain-language summary

A prospective, observational cohort study designed to identify clinical phenotypes and evaluate predictors \& outcomes of functional mitral and tricuspid valve regurgitation in patients with atrial fibrillation. Participant will under go: * Baseline echocardiography * Cpex Echocardiography * Blood test: BNP * 1 year follow up Echocardiography Participants will be stratified into three subgroups: * Atrial Functional MR * Atrial Functional TR * Mixed MR \& TR

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Informed consent * Age of 18 years or older * Atrial fibrillation * Moderate or severe atrial valve disease * Adequate 2D echocardiography views including parasternal long axis, short axis, apical two chamber, apical three chamber and four chamber. Exclusion Criteria: * Unwilling or unable to give consent * Left ventricular impairment (ejection fraction \< 50%). * Primary/organic valve disease

What they're measuring

Effective Regurgitant Orifice Area at 1 year

Timeframe: 1 year

Trial details

NCT IDNCT05920824

SponsorBarts & The London NHS Trust

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-08

Contact for this trial

Jawza Aldakhil

00447899770693 Jawza@outlook.sa

View on ClinicalTrials.gov More Atrial Fibrillation trials